Clinical Trial Update: Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating clopidogrel for primary prevention in patients with coronary artery disease, with recruitment ongoing. The HOST-PREVENTION s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING